|
ACMA Think Tank Series: AI In Medical Affairs Report (40+ pages)
Think Tank Report
| 
Pioneering the Future of the Pharmaceutical Industry
What's included?
- - 40+ pages providing a deep dive into all aspects of AI in the life sciences, with a particular focus on medical affairs
- - Insider insights that help you unlock how pharma will leverage AI
- - Key understanding of what pharma is using AI for and how to implement effectively & compliantly
- - Data & statistics focusing on AI in medical affairs & the life sciences
$499.99
$999.99
Download full think tank report
Think tank target audience
C-suite pharma/biotech/life sciences industry
Directors/VP Medical Affairs
Technology/AI officers & leaders
Directors/VP Market Access
Healthcare System Administrators
Pioneering the Future of the Pharmaceutical Industry
Topics covered in think tank
- Evolving Landscape of AI in Medical Affairs
- Leadership Perspectives on AI Adoption
- Collaborative Development of AI Tools
- Scaling AI Initiatives
- Ensuring Trust and Accuracy
ACMA Think Tank Series: AI In Medical Affairs Report (40+ pages)
Harnessing the Healthcare Data Deluge for Informed Medical Affairs
The amount of healthcare data available is estimated to have reached 2 zettabytes, or 2 trillion gigabytes, in 2022. This explosion in data provides a unique opportunity for better medical affairs decision making.
Navigating the Evolution of AI Integration in Medical Affairs
How is the discussion surrounding the integration of AI evolving within medical affairs teams?
Addressing AI Adoption Concerns in Medical Affairs
In adopting AI, what are the primary concerns and considerations voiced by medical affairs leaders, and how are these challenges being addressed?
Stakeholder Collaboration in AI-Enabled Evidence Generation
By 2030, it's anticipated that AI tools will be able to scan internal and external databases for signal detection and trial design. In the development of such evidence-generation tools, which stakeholders do you believe should be involved?
Medical Affairs Teams
AI impact on medical information teams
Shaping the Future
For nearly a decade, ACMA has set the standards of excellence in pharmaceutical practice.
Our Think Tank Series embodies our commitment to research and innovation, focusing on how to best leverage technology and data to inform decision-making processes.
About the ACMA Think Tank
Founded on the principle of fostering excellence within the pharmaceutical industry, ACMA Think Tank is dedicated to offering unparalleled expertise. By assembling a distinguished community of thought leaders from the world's leading pharmaceutical companies, we ensure access to groundbreaking insights and the latest advancements in medical science.